乳腺癌放疗靶区勾画保乳术后放疗(LN+)保乳术后放疗(LN-)tothoseformastectomyEBCTCG:2011Lancet2011,378:1707根治术后放疗LANCET,201421基因评分对于NSABPB-14andB-20LN阴性患者局部区域复发的价值PrognosticPredictiveMamounasEPetal
JCO2010;28:1677-1683©2010byAmericanSocietyofClinicalOncologyMamounasEPetal
JClinOncol30,2012(suppl27;abstr1)21基因评分对于NSABPB-28LN阳性患者局部区域复发的价值18基因评分7Cellcycleandproliferation:(DDX39,BUB1B,STIL,TPX2,CCNB1),Sustainedproliferation:Oncogenicprocess(BLM,TCF3,PIM1,RCHY1,PTI1),Tumor-promotinginflammationandavoidingimmunedestruction:(CCR1,NFATC2IP),Cell-cellinteractionandEMT:(TRPV6,OBSL1,MMP15),Resistancetoapoptosis(C16ORF7,DTX2(Notch))Alteredmetabolism:(ENSA)18基因评分比34基因进一步改进5fromAffymetrixU95toU133Plus2
0arrayP=0
00834-GenePanelJCO2006;24:4594-460218-GeneClassifierEBioMedicine2016;5:74-81NCCN2017,V2NCCN2017,V2放疗原则个体化放疗计划和实